Sep 7, 2023 路 PULMICORT RESPULES is available in three strengths, each containing 2 mL: 0.25 mg/2 mL, 0.5 mg/2 mL, and 1 mg/2 mL. PULMICORT RESPULES is supplied in sealed aluminum foil envelopes containing one plastic strip of five single-dose RESPULES ampules together with patient instructions for use. There are 30 RESPULES ampules in a carton. Aug 4, 2000 路 Budesonide, the active component of PULMICORT RESPULES脭, is a corticosteroid designated chemically as (RS)-11b, 16a, 17, 21-tetrahydroxypregna-1, 4-diene-3, 20-dione cyclic 16, 17-acetal with butyraldehyde. Budesonide is provided as a mixture of two epimers (22R and 22S). The empirical formula of budesonide is C25H34O6 and its molecular weight Jan 12, 2021 路 Budesonide inhalation suspension is available in two strengths, each containing 2 mL: 0.25 mg/2 mL and 0.5 mg/2 mL. Budesonide inhalation suspension is supplied in sealed aluminum foil envelopes containing one plastic strip of five single-dose vials. There are 30 vials in a carton. Each single-dose vial contains 2 mL of sterile liquid suspension. Oct 4, 2022 路 A study in CD-1 mice given albuterol sulfate subcutaneously showed cleft palate formation in 5 of 111 (4.5%) fetuses at 0.25 mg/kg (less than the maximum recommended daily inhalation dose for adults on a mg/m 2 basis) and in 10 of 108 (9.3%) fetuses at 2.5 mg/kg (approximately equal to the maximum recommended daily inhalation dose for adults on Albuterol has an average rating of 3.2 out of 10 from a total of 389 ratings on Drugs.com. 19% of reviewers reported a positive effect, while 71% reported a negative effect. Budesonide has an average rating of 6.5 out of 10 from a total of 140 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 26% reported a negative effect. Nov 3, 2023 路 Initial dose: 0.25 mg subcutaneously once a week for 4 weeks, then 0.5 mg subcutaneously once a week. If additional glycemic control is needed after at least 4 weeks receiving 0.5 mg dose subcutaneously once a week, may increase to 1 mg subcutaneously once a week. Maintenance dose: 0.5 to 1 mg subcutaneously once a week. Maximum dose: 1 mg/week. The usual dosage for adults and children 12 years of age and older is 2.5 mg of albuterol administered three to four times daily by nebulization. More frequent administration or higher doses are not recommended. To administer 2.5 mg of albuterol, dilute 0.5 mL of the 0.5% inhalation solution with 2.5 mL of sterile normal saline solution. Budixon Neb 0,250 mg/ml sk艂ad: Substancja czynna. Substancj膮 czynn膮 leku jest budezonid. 1 ml zawiesiny do nebulizacji zawiera: 0,250 mg budezonidu zmikronizowanego. 1 pojemnik plastykowy zawiera 0,5 mg budezonidu w 2 ml zawiesiny do nebulizacji. Pozosta艂e sk艂adniki. Pulmicort Respules庐 Budesonide 0.5 mg / 2 mL Suspension Nebulizer Ampule 30 Ampules AstraZeneca Pharmaceuticals 00186198904 AstraZeneca Pharmaceuticals 00186198904 - McKesson Medical-Surgical McKesson The highest recommended dose in children is 400 mcg twice daily. *In patients with mild to moderate asthma who are well controlled on inhaled corticosteroids, dosing with Budixon Neb (Budixon Neb) 200 mcg or 400 mcg once daily may be considered. Budixon Neb (Budixon Neb) can be administered once daily either in the morning or in the evening. DGaqa.